Fig. 7From: Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3–4 NSCLC patientsIdentification of potential agents in each cluster. Differential drug response analysis of compounds identified in cluster-1 (A), cluster-2 (B), and cluster-3 (C). Note that higher estimated AUC values imply lower drug sensitivity. ***, P < 0.001; **, P < 0.01; *, P < 0.05Back to article page